Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial
Aniek E.M. Schouten(Utrecht University), Anne M. May(Utrecht University), Evelyn M. Monninkhof(University Medical Center Utrecht), Martijn M. Stuiver(Amsterdam Public Health), Wolfram Malter(University of Cologne), Joachim Wiskemann(Heidelberg University), J.H. Müller(Heidelberg University), Prudence A. Francis(Peter MacCallum Cancer Centre), Jon Belloso(Osakidetza), Anouk E. Hiensch(Utrecht University), Miriam P. van der Meulen(Utrecht University), Maike G. Sweegers(Amsterdam UMC Location Vrije Universiteit Amsterdam), Rhodé M. Bijlsma(Utrecht University), Eva M. Zopf(Cabrini Hospital), Nadira Gunasekara(German Sport University Cologne), Gabe S. Sonke(The Netherlands Cancer Institute), Joanna Kufel-Grabowska(Greater Poland Cancer Center), Carlo Fremd(German Cancer Research Center), Elżbieta Senkus(Gdańsk Medical University), Martina E. Schmidt(German Cancer Research Center), Ainhara Lahuerta(Osakidetza), G. Bruce Mann(The Royal Melbourne Hospital), Wilhelm Bloch(German Sport University Cologne), Yvonne Wengström(Karolinska University Hospital), Ander Urruticoechea(Osakidetza), Helene Rundqvist(Karolinska Institutet), Renske Altena(Karolinska University Hospital), Neil K. Aaronson(The Netherlands Cancer Institute), Karen Steindorf(German Cancer Research Center), Elsken van der Wall(Johns Hopkins University), Dorothea Clauss(German Sport University Cologne), Mark Trevaskis(Australian Catholic University), Geert Frederix(University Medical Center Utrecht), Gary Richardson(Cabrini Hospital)
Cited by 7
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k